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BACKGROUND: Current organotypic models of dysplasia and oral squamous cell carcinoma (OSCC) lack the complexity that mimics in
vivo tissue. Here we describe a three-dimensional in vitro model of the oral epithelium that replicates tumour progression from
dysplasia to an invasive phenotype.
METHODS: The OSCC cell lines were seeded as a cell suspension (D20, Cal27) or as multicellular tumour spheroids (FaDu) with oral
fibroblasts on to a de-epidermised acellular dermis to generate tissue-engineered models and compared with patient biopsies.
RESULTS: The D20 and Cal27 cells generated a model of epithelial dysplasia. Overtime Cal27 cells traversed the basement membrane
and invaded the connective tissue to reproduce features of early invasive OSCC. When seeded onto a model of the normal oral
mucosa, FaDu spheroids produced a histological picture mimicking carcinoma in situ with severe cellular atypia juxtaposed to normal
epithelium.
CONCLUSION: It is possible to culture in vitro models with the morphological appearance and histological characteristics of dysplasia and
tumour cell invasion seen in vivo using native dermis. Such models could facilitate study of the molecular processes involved in
malignant transformation, invasion and tumour growth as well as in vitro testing of new treatments, diagnostic tests and drug delivery
systems for OSCC.
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Head and neck squamous cell carcinoma (HNSCC), which includes
oral squamous cell carcinoma (OSCC), is the sixth most common
malignancy worldwide (Argiris et al, 2008), and despite improved
patient outcomes in a range of cancers the prognostic implications
of HNSCC remain poor. With no established screening methods,
visual identification of oral cancers is imperative for early
detection, although recent developments of aneuploidy analysis
for premalignant lesions may help to predict those lesions at risk
of developing malignancy (Torres-Rendon et al, 2009; Bradley
et al, 2010). Premalignant lesions have a variety of clinical
presentations and may present as leukoplakia (white patch) or
erythroplakia (red patch). Although erythroplakia is more likely
to show histological features of dysplasias that then progress to
OSCC, only a small proportion of all premalignant lesions progress
to malignancy (Reibel, 2003).
Numerous aetiological factors are involved in the transforma-
tion of normal oral mucosa (NOM) to premalignant dysplastic
lesions that may then develop into oral carcinoma (Jefferies and
Foulkes, 2001; Leemans et al, 2011). Using molecular techniques to
examine loss of heterozygosity, gene mutations and gene
transcription patterns, investigators have shown that oral carci-
nogenesis is a progressive multistep process resulting from the
clonal expansion of a cancer stem cell with a TP53 mutation.
Initially, a small patch of these mutated cells are present in the oral
mucosa. These cells then acquire additional cancer-related genetic
alterations and expand to form a larger field of abnormal cells that,
with the acquisition of further genetic changes, then progress to
invasive cancer (Califano et al, 1996, 2000; Braakhuis et al, 2003).
In fact, current evidence suggests that oral premalignant lesions
share genetic alterations and transcription profiles that are closer
to the malignant lesions they go on to form than the transcription
profiles of premalignant lesions that do not progress to cancer (Ha
et al, 2003; Hunter et al, 2006). Thus, it seems that OSCC genetic
signatures are already embedded in the premalignant cells that are
destined to progress to malignancy.
Histological analysis of epithelial dysplasia is graded as mild,
moderate or severe depending on the extent of atypia in the oral
mucosa. Full-thickness dysplasia is classified as carcinoma in situ
and only becomes an early invasive OSCC once tumour cells have
penetrated through the basement membrane and infiltrated into
the connective tissue. The clinical appearance of a dysplastic lesion
is not a good guide to the level of dysplasia, and hence potential
malignancy or malignancy can only be assessed by biopsy and
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histopathological evaluation. Despite recent therapeutic develop-
ments (Mao et al, 1998; Rudin et al, 2003; Rhee et al, 2004), there is
currently no effective treatment for dysplasia but to reduce the
associated risk factors for malignant change, such as smoking and
alcohol consumption, and to monitor for malignant progression.
Although a valuable tool in oral cancer research, monolayer
cultures of epithelial cells do not achieve the complexity of the oral
mucosa in vivo. Important features innate to this organised tissue,
such as cell–cell interactions, control of proliferation, differentia-
tion, the deposition of a basement membrane and the controlling
influence of the connective tissue (Moharamzadeh et al, 2007), are
all lost in monolayer culture. Xenograft animal tumour models or
tumours generated by epithelial transformation using chemical
carcinogens have been successful in identifying important genes,
molecules and mechanisms involved in oral cancer development
and progression (Kim, 2009). Although several in vivo models for
studying head and neck are available, none are fully satisfactory as
they are often difficult to establish, produce varying results and
raise important questions about the genetic differences between
humans and animals, and whether xenograft or chemically
induced tumour models are representative of human oral cancer
(Prime et al, 1986; Kim, 2009).
Tissue-engineered three-dimensional (3D) models of the NOM
are now well established for in vitro investigations (reviewed in
Moharamzadeh et al, 2007) and have more recently been used for
clinical applications (Bhargava et al, 2008). The keratinocyte
organotypic co-culture model originally developed by Fusenig et al
(1983) has been used by investigators to mimic oral dysplasia or
cancer (Nystrom et al, 2005; Costea et al, 2006; Vigneswaran et al,
2006; Gaballah et al, 2008; Marsh et al, 2011). This method involves
the culture of keratinocytes at an air-to-liquid interface on a
fibroblast-containing collagen type I matrix. Interactions between
the mesenchyme and epithelium are essential for normal
epithelium development and maintenance. Crosstalk between the
stroma and the overlying epithelium is known to influence a
number of processes including keratinocyte proliferation, migra-
tion, differentiation and the formation of a basement membrane at
the epithelial-dermal junction (EDJ) by synthesis of extracellular
matrix (ECM) components (Saintigny et al, 1993). It is therefore
not surprising that the stromal microenvironment is known to play
a significant role in tumour invasion and progression (Mueller and
Fusenig, 2004; Marsh et al, 2011). However, the basic homo-
geneous structure of the connective tissue (Wolf et al, 2009) and
lack of a native basement membrane (Chung et al, 1997; Yadev et al,
2011) in collagen-based models allows only a simplistic representa-
tion of the native stromal component. Mucosal models that utilise
a more complex, native, connective tissue containing a defined
basement membrane to investigate oral dysplasia and invasive
carcinoma may provide a greater insight into the molecular
mechanisms controlling premalignant dysplasia and invasion in vivo.
The aim of this study was to develop and optimise a tissue-
engineered, full-thickness model of squamous cell carcinoma of
the oral mucosa from a dysplastic phenotype to early invasion
using native human dermis. Such models could facilitate study of
the mechanistic aspects of disease processes that are involved in
malignant transformation, early invasion and tumour growth as
well as facilitate final stage in vitro testing of new treatments,
diagnostic tests and drug delivery systems for OSCC.
MATERIALS AND METHODS
Culture of HNSCC cell lines
This study used the following HNSCC cell lines: Cal27 (American
Tissue Culture Collection (Manassas, VA, USA), CRL-2095) that
was originally isolated from a 56-year-old Caucasian male with a
squamous cell carcinoma of the tongue (Gioanni et al, 1988); FaDu
(LGC Promochem, Middlesex, UK) that was isolated from a
hypopharyngeal tumour (Rangan, 1972); DOK (ECACC, Health
Protection Agency Culture Collections, Salisbury, UK), a dysplastic
oral keratinocyte cell line that was originally isolated from the
dorsal tongue of a 57-year-old male (Chang et al, 1992); and D20
that was derived from a lateral tongue dysplasia (McGregor et al,
1997). Cal27 and DOK cells were routinely cultured in Dulbecco’s
modified Eagle’s medium (DMEM) and FaDu cells in RPMI-1640
supplemented with 10% (v/v) fetal calf serum (FCS; BioSera, East
Sussex, UK), 2mM L-Glutamine, 100 IUml–1 penicillin and
100mgml–1 streptomycin (Sigma, Poole, UK). Medium for the
culture of DOK cells was also supplemented with 5 mgml–1
hydrocortisone. D20 cells were cultured in flavin- and adenine-
enriched medium: DMEM and Ham’s F12 medium in a 3 : 1 (v/v)
ratio supplemented with 10% (v/v) FCS, 0.1 mM cholera toxin,
10 ngml–1 of epidermal growth factor (EGF), 0.4 mgml–1 hydro-
cortisone, 0.18mM adenine, 5 mgml–1 insulin, 5 mgml–1 transfer-
rin, 2mM glutamine, 0.2 mM triiodothyronine, 0.625 mgml–1
amphotericin B, 100 IUml–1 penicillin and 100 mgml– 1 strepto-
mycin (Allen-Hoffmann and Rheinwald, 1984).
Flow cytometry
Keratinocytes were removed from tissue culture flasks non-
enzymatically, centrifuged at 250 g for 5min and re-suspended at
1 107 cells per ml in cold PBS supplemented with 0.1% BSA, 0.1%
sodium azide (FACs buffer) and kept on ice. Cells (5 105 cells)
were incubated for 30min on ice with 10 mgml–1 anti-avb6 mouse
monoclonal antibody (clone 6.3G9) or IgG isotype-matched
control. Following washes with FACs buffer, cells were incubated
with AlexaFlour 488-conjugated anti-mouse antibody (Invitrogen,
Paisley, UK) for 30min on ice in the dark, then washed twice and
re-suspended with FACs buffer. Flow cytometry was performed
using a FACsCalibur (Becton Dickinson, San Jose, CA, USA);
propidium iodide was used to gate out nonviable cells and
data were analysed using CellQuest Software (Becton Dickinson).
Multicellular tumour spheroid (MCTS) production
Multicellular tumour spheroid were generated from FaDu cells
using the liquid overlay method as previously described (Carlsson
and Yuhas, 1984). Briefly, 100 ml of FaDu cells (1.2 105 per ml)
were added to each well of a 96-well plate previously coated with
1.5% type V agarose (w/v in RPMI). The cells were incubated at
37 1C, 5% CO2 and monitored at 24 h for MCTS production.
Medium was changed every 48 h by removing and re-placing 50%
of the medium.
Primary human oral keratinocyte and fibroblast isolation
Normal oral keratinocytes (NOKs) and fibroblasts (NOFs) were
isolated from biopsies obtained from the buccal and gingival oral
mucosa from patients during routine dental procedures with
written, informed consent (ethical approval number 09/H1308/66)
as previously described (Hearnden et al, 2009). Briefly, biopsies
were incubated overnight at 4 1C in 0.1% w/v trypsin solution
supplemented with 100 IUml penicillin, 100mgml–1 streptomycin
and 0.625mgml–1 amphotericin B. Following enzymatic digestion,
the epithelium was removed from the connective tissue and oral
keratinocytes isolated by gently scraping the papillary surface of
the epithelium and the uppermost side of the connective tissue
layer. Keratinocytes were cultured on irradiated mouse 3T3 feeder
layers in flavin- and adenine-enriched medium.
The NOFs were isolated from the connective tissue by fine
mincing followed by digestion with 0.5% (w/v) collagenase A
overnight at 37 1C. The NOFs were collected by centrifugation and
then cultured in DMEM supplemented with 10% FCS, 2mM
glutamine, 100 IUml–1 penicillin and 100 mgml–1 streptomycin.
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Production of de-epidermised acellular dermis (DED)
De-epidermised acellular dermis was produced from either split-
thickness skin grafts or commercially available cadaver skin
(Euroskin, Beverwijk, Holland) and processed as previously
described (Eves et al, 2000). Split-thickness skin grafts were
immersed in 1M sodium chloride for 24 h at 37 1C to allow removal
of the epidermis. The resultant DED samples were then washed
extensively in PBS and stored at 4 1C in DMEM until use.
Production of tissue-engineered oral mucosal models
De-epidermised acellular dermis was incubated in fresh DMEM for
48 h at 37 1C to confirm sterility. Then, 15mm2 pieces were
transferred to six-well plates (papillary surface uppermost) and an
8mm diameter steel ring placed on top of each piece and
immersed in medium. Tissue-engineered normal oral mucosa
models (TENOM), (Figure 1A) were produced by seeding 5 105
NOKs and 5 105 NOFs in the centre of the steel ring. For the
tissue-engineered dysplastic oral mucosa models (TEDOM,
Figure 1B), either 2.5 105 Cal27 or D20 cells and 5 105 NOFs
were used, and for the tissue-engineered early invasive oral
carcinoma (TEIOC, Figure 1B) models, 2.5 105 Cal27 cells and
5 105 NOFs were used. Medium within the ring was replaced
after 24 and 48 h. After 72 h, the ring was removed and the
composites placed on to stainless steel grids with medium added to
the underside of the composite model to allow culture at the air-to-
liquid interface. To generate tissue-engineered carcinoma in situ
(TECIS), (Figure 1C) models, 7-day-old FaDu MCTS were added to
TENOM. For all models, medium was changed 2–3 times a week
and the composites fixed at day 14 for TENOM, TEDOM, TECIS
and at day 21 for TEIOC in 10% buffered formalin for 48 h. All
models were then bisected and paraffin embedded.
Immunohistochemistry
Paraffin-embedded tissue sections (5 mm) were prepared from
tissue-engineered mucosal models and for comparative purposes
from paraffin-embedded blocks of NOM and archival HNSCC
biopsies in accordance with the Sheffield Research Ethics
Committee approval (Ref: 07/H1309/105). Sections were dewaxed,
rehydrated and either stained with haematoxylin and eosin (H&E)
or subjected to immunohistochemistry, in which case endogenous
peroxidase was neutralised with 3% hydrogen peroxide for 20min.
Following antigen retrieval, sections were blocked using protein-
free blocking solution (Dako, Copenhagen, Denmark) for 20min at
room temperature and then mouse monoclonal primary antibody
(diluted in PBS) applied for 1 h at room temperature (see Table 1
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Figure 1 Schematic illustration showing the methodology for producing the full-thickness tissue-engineered oral mucosal models. To produce the tissue-
engineered normal oral mucosa model (TENOM), normal oral fibroblasts (OFs) and normal oral keratinocytes (NOKs) were seeded onto a DED scaffold
within a 0.8 cm2 steel ring. After 72 h, the composites were raised to an air/liquid interface and cultured for a further 14 days (A). To recreate an in vitro
model of dysplastic oral mucosa (TEDOM) and early invasive oral carcinoma (TEIOC), the NOKs were replaced with OSCC cells (Cal27 or D20) and
cultured for either 14 or 21 days, respectively (B). The addition of a MCTS to the TENOM produced a model closely mimicking carcinoma in situ (TECIS) (C).
Table 1 Antibodies and antigen retrieval conditions used in this study
Marker Antibody clone Dilution/final concentration Antigen retrieval Source
Ki67 MIB-1 1 : 50 0.01 M sodium citrate buffer Dako, Copenhagen, Denmark
AE1/AE3 AE1/AE3 1 : 100 0.01 M sodium citrate buffer Dako
Collagen IV COL-94 1 : 500 0.01 M sodium citrate buffer Sigma, Poole, UK
avb6 6.2A1 0.5 mgml – 1 Proteinase K Generated as described in Weinreb et al (2004)
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for antibodies, dilutions and antigen retrieval method used).
Secondary antibody and avidin-biotin complex (ABC) provided
with Vectastain Elite ABC kit (Vector Labs, Peterborough, UK)
were then used in accordance with the manufacturer’s instructions.
Finally, 30-diaminobenzidine tetrahydrochloride (DAB) (Vector
Labs) was used to visualise peroxidase activity and the sections
were counterstained with haematoxylin, dehydrated and mounted
in DPX. Images were taken using an Olympus BX51 microscope
and Colour view IIIu camera with associated Cell^D software
(Olympus Soft Imaging Solutions, GmbH, Mu¨nster, Germany).
RESULTS
Full-thickness tissue-engineered normal oral mucosa model
To generate a full-thickness TENOM, oral keratinocytes and oral
fibroblasts were cultured on a DED scaffold at an air-to-liquid
interface for 14 days. The oral keratinocytes migrated and
proliferated laterally over the dermis as evident from cross-
sectional histological analysis with the epithelia at the centre of the
composite being thicker and tapering off towards the edges
(data not shown). Histologically, the TENOM demonstrated
normal architectural morphology, epithelial maturation and sur-
face keratinisation, a convoluted EDJ and a fibroblast-populated
dermis that closely replicates the histological appearance of NOM
(Figure 2A and F). A similar proliferation index to NOM was
evident upon Ki67 staining with proliferating cells predominately
located in the basal or para-basal cell layer (Figure 2B and G). The
pan-cytokeratin antibody anti-AE1/3 showed positive expression
throughout the thickness of the TENOM epithelium with increased
intensity in the lower third of the epithelium and was comparable
to the NOM (Figure 2C and H). Immunohistochemical staining for
collagen IV, a component of basement membranes, showed that
TENOM forms a basement membrane at the junction of the
epithelium and the underlying connective tissue, as well as around
vascular spaces in the connective tissue, similar to that seen in
NOM (Figure 2D and I). Finally, an antibody against integrin avb6
(Weinreb et al, 2004) revealed positive staining associated with the
keratinocytes in the basal cell layer of both NOM and TENOM
(Figure 2E and J).
Tissue-engineered dysplastic oral mucosa model
During the transformation from normal to premalignant lesions,
normal proliferation and differentiation of the mucosal epithelium
is disrupted, resulting in a dysplastic architecture. In dysplastic
oral mucosa, the rete processes become rounded, drop-shaped and
bulbous, and there is loss of normal keratinocyte maturation. To
model these changes in vitro, NOKs used for the TENOM were
replaced with the dysplastic cell line D20 or malignant Cal27 cells
and again seeded with NOFs on to a DED scaffold. The TEDOM
displays architectural and cytological changes typically associated
with clinical lesions histologically classified as severely dysplastic.
Similar to the clinical lesion, the TEDOM for both D20 and Cal27
cells show bulbous rete processes and abnormal keratinocyte
maturation (Figure 3A, F and K). In addition, abnormal
keratinocyte proliferation patterns are evident in the models and
match that seen in the dysplastic biopsy with proliferating cells
extending well into the supra-basal epithelial layers (Figure 3B, G
and L). The ratio of ki67-positive cells to nonproliferating cells is
similar in the biopsy compared with D20 and Cal27 models and
there is an increased proliferation index of Ki67-positive epithelial
cells along with abnormally high levels of mitotic figures (Figure
3B, G and L). The resultant loss of normal maturation and
disrupted keratinocyte differentiation is also evidenced by AE1/3
staining (Figure 3C, H and M). Further cytokeratin profile staining
showed positive expression of CK5/6 in both D20 and Cal27
models, which is characteristic of oral tumours, whereas staining
for CK7 (characteristic of lung and ovarian tumours) or CK20
(characteristic of colonic or pancreatic tumours) was negative
(data not shown). However, despite these histological changes,
immunohistochemical staining for collagen type IV shows a well-
defined, continuous basement membrane with no evidence of
malignant invasion and clearly mimics the in vivo situation of
dysplastic epithelium (Figure 3D, I and N). Expression of avb6 is
dramatically changed in DOM where it is expressed erratically
throughout the entire epithelium as well as on some basal cells. A
similar pattern of avb6 expression was observed in the TEDOM of
D20 and Cal27 models when compared with expression in DOM
(Figure 3E, J and O). Similar results to those described above were
also found using the dysplastic cell line DOK (Supplementary
Figure 1).
Tissue-engineered model of a severely dysplastic
epithelium (carcinoma in situ) surrounded by normal oral
mucosa
Biopsies are routinely taken from the visual boundary of the oral
lesion to allow histological examination of normal epithelium
juxtaposed to diseased tissue. A tissue-engineered model contain-
ing both a dysplastic and normal element would therefore be
valuable to enable examination of the interface between diseased
and normal tissue in parallel. To model this, the OSCC FaDu cell
line was cultured as a MCTS (to enable easy manipulation of the
cells into the desired position; Cal27 cells do not produce
satisfactory MCTS and hence were not used in this model) and
incorporated within a TENOM. The model produced a histological
picture closely resembling carcinoma in situ with a highly
disorganised epithelial architecture showing severe cytological
atypia involving the entire thickness of the epithelium and lying
adjacent to an otherwise normal epithelium (Figure 4A and F).
High proliferation indices with large numbers of Ki67-positive
supra-basal keratinocytes for FaDu cells in the TECIS model and
dysplastic cells in the oral biopsy were seen in contrast to the
typical intermittently Ki67-positive polarised para-basal cells in
the adjacent areas of TENOM and NOM (Figure 4B and G). In the
TECIS model the FaDu cells showed reduced expression of
keratins, staining weakly for the pan-cytokeratin marker AE1/3
in comparison with the adjacent ‘normal tissue’ that was stained
throughout the epithelium. This was in contrast to the oral biopsy
that showed disrupted AE1/3 cytokeratin staining throughout the
dysplastic epithelium (Figure 4C and H). Comparable to the CIS
biopsy, FaDu cells in the TECIS did not penetrate the basement
membrane and invade into the underlying connective tissue, and a
collagen IV-positive intact basement membrane was present in
both cases (Figure 4D and I). Expression of avb6 was weak in both
CIS and TECIS and the expression was restricted to the basal
epithelial cells (Figure 4E and J). Flow cytometric analysis showed
that NOK, DOK, Cal27 and FaDu all express cell surface avb6 when
grown as monolayer cultures (Figure 5), suggesting that expression
of this receptor dramatically changes when grown in 3D models
and may be associated with a less well-differentiated phenotype.
Tissue-engineered model of early invasive oral squamous
cell carcinoma
The progression from dysplasia to an invasive oral carcinoma is
histopathologically defined when islands and cords of malignant
epithelial cells arising from the overlying dysplastic mucosa invade
through the basement membrane into the lamina propria. To
model this, the TEDOM was further cultured for another 7 days, by
which time histological analysis revealed that tumour cells had
infiltrated the basement membrane and invaded the underlying
stroma as evident by the presence of tumour islands within the
connective tissue (Figure 6A and F). Similar results were observed
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when TEIOC models were made from the OSCC cell lines SCC9,
SCC25, PE/CA-PJ34 and FaDu, and then cultured for 14–21 days at
an air-to-liquid interface. In contrast, the OSCC cell line SCC4
failed to generate TEIOC models (Supplementary Figure 2).
Immunohistochemical analysis confirmed that this TEIOC repre-
sents a histological picture of naturally occurring early invasive
NOM TENOM
H&E
Ki67
AE1/3
Col IV
v6
Figure 2 Representative sections of normal oral mucosa taken from patient biopsies (NOM) (A–E) and tissue-engineered normal oral mucosa
constructs (TENOM) (F– J). TENOM models were generated by culturing normal oral keratinocytes and normal oral fibroblasts on DED at an air/liquid
interface for 14 days. Sections have been stained with H&E (A and F) and immunohistochemically stained to show the pattern of expression of Ki67 (B and
G), AE1/3 (C and H), collagen type IV (Col IV; D and I) and integrin avb6 (E and J) and counterstained with haematoxylin. Scale bar indicates 200 mm.
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OSCC. Positive staining for pan-cytokeratin and cytokeratin 5/6
and negative staining for cytokeratin 7 and 20 confirmed that the
invaded cells were of oral epithelial origin (Figure 6C and H, and
data not shown). Collagen type IV staining showed that the
basement membrane along the EDJ was completely disrupted
and replicates the in vivo situation (Figure 6D and I). Although
the epithelial cells in the invasive cancer model are not as
proliferative as in the invasive OSCC, the TEIOC shows an
abnormal proliferation profile with cells staining positively for
ki67 throughout the epithelium and proliferating cells within the
invading tumour island (Figure 6B and G). Expression of avb6 was
patchy but widely distributed throughout the dysplastic epithelium
as well as in the islands of invasive OSCC, but expression was
weak in the TEIOC model (Figure 6E and J) despite flow cytometric
analysis showing strong avb6 staining on monolayer cultures
(Figure 5C).
DISCUSSION
In this study we present the development of a tissue-engineered 3D
model of the oral mucosa using a native complex dermal matrix to
produce three in vitro models demonstrating histopathological
malignant transformation through dysplasia, carcinoma in situ to
early invasive carcinoma. The models were closely compared with
their in vivo counterpart with regard to the architectural and
cytological changes observed. Furthermore, we used the models
to investigate the expression of the integrin avb6 at different stages
of cancer progression and compared these with patient biopsies, as
dysregulated expression of this integrin has been previously
associated with dysplasia and carcinogenesis (Thomas et al, 2001b;
Nystrom et al, 2006).
Histological examination of the TENOM revealed that normal
keratinocytes proliferated to produce a stratified squamous
DOM
TEDOM
Cal27
TEDOM
D20
H&E
Ki67
AE1/3
Col IV
v6
Figure 3 Representative sections of dysplastic oral mucosa taken from patient biopsies (DOM) (A–E) and tissue-engineered dysplastic oral mucosa
constructs (TEDOM) (F– J). TEDOM models were generated by culturing D20 or Cal27 cells and normal oral fibroblasts on DED at an air-to-liquid interface
for 14 days. Sections were stained with H&E (A, F and K) and immunohistochemically stained to show the pattern of expression of Ki67 (B, G and L), AE1/3
(C, H and M), collagen type IV (Col IV; D, I and N) and integrin avb6 (E, J and O) and counterstained with haematoxylin. Scale bar indicates 200mm.
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TECISCIS
H&E
Normal CIS
CIS
Ki67
AE1/3
Col IV
v6
Normal
Figure 4 Representative sections of oral mucosa taken from patient biopsies pathohistologically classified as carcinoma in situ (CIS) (A–E) and a tissue-
engineered model of carcinomas in situ (TECIS) (F– J). TECIS models were generated by the addition of a MCTS to the TENOM model and further culture
at an air/liquid interface for 14 days. Sections have been stained with H&E (A and F) and immunohistochemically stained to show the pattern of expression
of Ki67 (B and G), AE1/3 (C and H), collagen type IV (Coll IV; D and I) and integrin avb6 (E and J) and counterstained with haematoxylin. Scale bar
indicates 200 mm. In each case, relatively normal tissue is seen to the left and CIS to the right of each section.
In vitro models of oral cancer progression
HE Colley et al
1588
British Journal of Cancer (2011) 105(10), 1582 – 1592 & 2011 Cancer Research UK
M
o
le
c
u
la
r
D
ia
g
n
o
stic
s
epithelium several layers thick that is consistent with previously
published reports (Cho et al, 2000; Bhargava et al, 2004;
Moharamzadeh et al, 2008). To produce a model of oral dysplasia,
NOKs were substituted with the dysplastic cell line, D20, or the
malignant OSCC cell line, Cal27. The histological changes observed
in both our TEDOM models are typical for a lesion classified as
premalignant dysplasia with increased numbers of proliferating
keratinocytes that are abnormally located in the supra-basal layers
and a degree of atypical maturation and architecture.
Dysplastic keratinocytes derived from clinical lesions have an
altered phenotype when cultured as 3D constructs with the degree
of dysplasia not matching that of the original lesion (Gaballah et al,
2008). This may be because lesions are a heterogeneous mix of
keratinocytes at different developmental stages and more atypical
cells may possess a survival advantage in culture (Gaballah et al,
2008). The aim of the current study was to produce a model system
that could easily be reproduced. The advantages of using a
dysplastic cell line include reproducibility, standardisation and to
avoid donor-dependant variations including age and site of
isolation, which often arise when using donor-derived cells.
Morphological and cytological changes are also consistent through
serial passage for immortal cell lines, which is not the case for
mortal dysplastic keratinocytes (Gaballah et al, 2008). Costea et al
(2006) showed that DOK cells were invasive in collagen-based
connective tissue organotypic models, whereas we found DOK cells
to be noninvasive in our native DED-based models. The DOK cells
are also nontumourigenic in mice (Chang et al, 1992), suggesting
that their invasion capacity is restricted by native ECM but not by
collagen alone and underscores the importance of using DED in
models of dysplasia.
True to the malignant progression of OSCC, further culture of
the Cal27 TEDOM led to breakdown of the basement membrane
and extensive epithelial tumour cell invasion into the connective
tissue component of the model that was analogous to early invasive
OSCC in vivo. Stromal fibroblasts appear to be crucial for tumour
invasion and progression (Kalluri and Zeisberg, 2006). During
transition from normal epithelium to malignancy, some fibroblasts
transdifferentiate into a-smooth muscle actin-expressing
myofibroblasts that facilitate oral tumour cell invasion (Lim
et al, 2011; Marsh et al, 2011). In this study marked invasion
into the connective tissue of the TEIOC model was evident even in
the presence of normal human oral fibroblasts (NOFs were
a-smooth muscle actin negative by immunohistochemistry;
data not shown). Using collagen-based models, Marsh et al
(2011) showed increased invasion of OSCC cells into the ECM in
the presence of myofibroblasts compared with NOFs, and no
invasion was observed in models without fibroblasts (Marsh et al,
2011). This suggests that OSCC invasion into the DED of our
models may be further enhanced if myofibroblasts were used in
place of NOFs.
Immunohistochemical analysis has shown that expression of
integrin avb6 is altered during the transition from NOM though
premalignant lesions to invasive oral cancer (Thomas et al, 1997,
2001b; Nystrom et al, 2006). It is also upregulated in mucosal
development, wound healing and areca (betel) nut-mediated oral
submucous fibrosis (Nystrom et al, 2006; Thomas et al, 2006;
Moutasim et al, 2011). The avb6 integrin appears to play an
important role in oral cancer cell invasion by directly upregulating
the expression of matrix metalloproteinase-9 and indirectly by
activating TGF-b that then promotes myofibroblast formation
(Thomas et al, 2001a; Lewis et al, 2004). The avb6-dependent
OSCC invasion also requires COX-2-dependent activation of Rac-1,
via upregulation of PGE2 (Nystrom et al, 2006). Similar to the
normal in vivo situation, we found avb6 expression localised to the
basal cells of the mucosal models even though flow cytometric
analysis showed abundant cell surface expression on all epithelial
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Figure 5 Flow cytometric analysis showing expression of cell surface avb6 on monolayer cultures of normal oral keratinocytes (A), DOK (B), Cal27 (C)
and FaDu (D). Histograms show expression of avb6 (open histogram) compared with isotype-matched control IgG (grey-filled histogram). The x axis is log
scale fluorescence.
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cells before seeding onto the DED, showing that 3D culture alters
the expression pattern of these molecules. Furthermore, similar
avb6 expression patterns were observed in both dysplastic and
invasive models when compared with biopsy, providing evidence
of the usefulness of these models in mimicking the situation
in vivo. The dysplastic and invasive models may therefore be
IOC TEIOC
H&E
Ki67
AE1/3
Col IV
v6
Figure 6 Representative sections of early invasive oral carcinoma (IOC) taken from patient biopsies (A–E) and a tissue-engineered invasive carcinoma
(TEIOC) (F– J). TEIOC were generated by culturing OSCC (Cal27) and normal oral fibroblasts on DED at an air/liquid interface for 21 days. Sections have
been stained with H&E (A and F) and immunohistochemically stained to show the pattern of expression of Ki67 (B andG), AE1/3 (C andH), collagen type
IV (Col IV; D and I) and integrin avb6 (E and J) and counterstained with haematoxylin. Scale bar indicates 200 mm.
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useful in future studies aimed at identifying the underlying
mechanisms of avb6-mediated tumour cell invasion.
One consideration, when producing the composites, was the
ability to model the transformation from a dysplastic to an
invasive phenotype. It was therefore important that the structural
integrity of the 3D construct was maintained throughout the
culture period. Bovine or rat-based collagen is often used for 3D
organotypic models because of their ease of use and reproduci-
bility, but these lack the complex structural heterogeneity and
degree of collagen fibre crosslinking that is present in mature
human oral connective tissue and they are not biostable over long
culture periods with artificial invasion possible (Wolf et al, 2009).
Furthermore, we and others have shown that these models do not
contain a well-defined, continuous basement membrane between
the epithelium and the connective tissue that is crucial in the
morphological development of the epithelium and its attachment
to the connective tissue (Chung et al, 1997; Ralston et al, 1999;
Yadev et al, 2011) as well as in defining the boundary of tumour
invasion. The collagen composition, organisation, fibre size and
orientation that produce heterogeneous pore sizes within the DED
are similar to what is seen in vivo (Wolf et al, 2009). Therefore, the
use of DED more closely models the connective tissue element of
the oral mucosa compared with collagen gels and enables long-
term culture of the models for up to 28 days. We suggest that the
complex nature of DED is the most physiologically relevant
material to test the ability of tumour cells to invade into the
connective tissue in vitro. However, these models do not contain a
vasculature or immune cell component that may influence tumour
cell invasion and hence may not be truly representative of in vivo
invasion.
In summary, we have established a novel 3D model of oral
dysplasia, carcinoma in situ and early invasive carcinoma that
allows the study of architectural and cytological changes within a
multilayered construct in a controlled microenvironment. The use
of cell lines and commercially available DED ensures that the
model is reproducible. Further applications could involve use in
final-stage anticancer drug screenings or adaptation of this model
to study other diseases and systems.
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